labcorp stock overview

Labcorp stock (Labcorp Holdings, Inc. — ticker: LH)

labcorp stock refers to the common shares of Laboratory Corporation of America Holdings (Labcorp), listed on the New York Stock Exchange under the ticker symbol LH. Labcorp is a major provider of clinical laboratory services and biopharma testing solutions. Investors follow labcorp stock for exposure to diagnostic testing volumes, growth in biopharma laboratory services, and trends in healthcare spending and reimbursement.

Infobox / Quick facts (stock summary)

Note: The numerical items above are time-sensitive. As of 2026-01-26, readers should verify live price, market cap, dividend, and ratios from Labcorp Investor Relations and major market data providers such as Yahoo Finance, MarketWatch, CNBC, Finviz, and Macrotrends.

Company overview

Labcorp is a global healthcare company focused on diagnostic testing and biopharma laboratory services. The company operates two principal business segments:

• Diagnostics Laboratories: Clinical laboratory testing for hospitals, physicians, and patients, spanning routine chemistry, immunology, molecular diagnostics, pathology services, and specialty testing.
• Biopharma Laboratory Services: Contract research and testing services that support drug development and clinical trials, including central laboratory services and drug development support.

Core services include routine blood and tissue testing, genomics and molecular assays, specialty testing (oncology, infectious disease), and clinical trial sample processing for pharmaceutical and biotechnology companies. Labcorp's scale and integrated services make it a key partner across diagnostics and the life sciences value chain.

The company has an international footprint with thousands of service locations, laboratories, and distribution points; it employs tens of thousands of people worldwide. Labcorp completed a significant strategic expansion into the biopharma services market historically (including the acquisition of a leading contract research organization), which diversified its revenue mix beyond patient-facing diagnostics. The company is headquartered in Burlington, North Carolina.

Stock market listing and identifiers

Labcorp's primary listing is on the New York Stock Exchange with the ticker symbol LH, trading in U.S. dollars (USD). Common identifiers used by investors include the company's ISIN and CUSIP; these identifiers are available in SEC filings and on corporate investor pages. There are no widely used ADR listings for Labcorp because the company is a U.S.-incorporated issuer with a primary NYSE listing.

Trading hours and market microstructure

Regular US equity trading hours are 09:30–16:00 ET on NYSE trading days, with pre-market and post-market sessions typically available on many trading platforms. Pre-market trading usually starts as early as 04:00–09:30 ET and post-market trading continues from 16:00–20:00 ET, subject to broker/platform rules.

Investor relations pages and many market data providers display delayed market quotes (commonly 15-minute delayed quotes). For example, consolidated market data shown on corporate IR may have a minimum 15-minute delay unless a real-time data license is provided.

Historical price performance

Long-term investors track labcorp stock performance across market cycles to assess total return, volatility, and sensitivity to healthcare trends. Historical price data and charts can be obtained from the Labcorp Investor Relations historical price lookup and third-party aggregators such as Macrotrends, Yahoo Finance, and MarketWatch.

Key points investors often look for:

• Multi-year total return relative to healthcare indices and peer diagnostics companies.
• Recent 52-week high and low to understand the current trading range.
• Notable price events tied to earnings releases, regulatory announcements, major acquisitions/divestitures, or macro healthcare news.

As market prices are updated continuously, use the listed data sources for accurate historical charts and downloadable price series when backtesting or performing historical analysis.

Stock splits and adjustments

Any historical stock splits, reverse splits, or corporate actions that affect share counts are documented in Labcorp's corporate history and SEC filings. Adjusted historical price series (which account for splits and dividends) are available on Macrotrends and other historical price providers — consult those resources when comparing long-term price performance.

Financial metrics and valuation

Investors evaluate labcorp stock using standard financial metrics. Important measures include revenue, net income, EBITDA, EPS (trailing twelve months), price-to-earnings (P/E) ratios (trailing and forward), enterprise value to EBITDA (EV/EBITDA), price-to-sales (P/S), and key margins (gross margin, operating margin, net margin).

Sources for these metrics include Labcorp's quarterly and annual reports, and market data aggregators (Yahoo Finance, Finviz, CNBC). Use forward estimates from analyst consensus to gauge how the market is pricing expected growth. Remember that valuation multiples for companies with sizable contract research operations can differ from pure-play diagnostics companies because revenue cyclicality and margin profiles vary.

Dividends and distribution policy

Labcorp has historically communicated dividend policy and payment details through investor relations. Dividend data — current dividend per share, yield, payment frequency, and payout ratio — change over time and should be confirmed on the company's IR page or major market quote pages.

When reviewing dividend information, examine the payout ratio relative to earnings and free cash flow to assess sustainability. Also check the company’s history of dividend increases or suspensions in annual filings and press releases.

Ownership and share structure

Publicly traded shares of Labcorp are held by a mix of institutional investors, mutual funds, and retail shareholders. Major institutional holders and insider ownership levels are disclosed in 13F filings, proxy statements, and Form 4 filings for insiders. Popular market snapshots (Finviz, Yahoo) provide lists of top institutional holders and an estimate of percent insider ownership.

Key items to monitor:

• Top institutional holders and their reported stake changes.
• Insider transactions — open-market purchases or sales reported via Form 4.
• Shares outstanding and float as disclosed in the most recent 10-Q/10-K.

Analyst coverage and market sentiment

Analyst ratings and price targets are aggregated by many financial news sites. For labcorp stock, investors watch the consensus mix of Buy/Hold/Sell recommendations, median price target, and recent rating changes by major brokers and research firms. Sites like CNBC and MarketWatch summarize analyst moves and provide context on earnings reactions and guidance updates.

Retail sentiment and short interest can also influence near-term price behavior. Retail platforms and market data aggregators provide community sentiment indicators and short interest data; use these together with fundamental analysis when reviewing market sentiment.

News, events, and catalysts

Events that commonly move labcorp stock include:

• Quarterly earnings releases and management guidance updates.
• Major acquisitions, divestitures, or strategic partnerships in diagnostics and biopharma testing.
• Regulatory developments affecting laboratory testing, reimbursement policies, or clinical trial conduct.
• Clinical and scientific milestones that affect demand for specialized testing services.
• Investor presentations at healthcare and investment conferences.

As of 2026-01-26, readers should consult Labcorp press releases and major financial news outlets for the most recent event coverage. Example: as reported by the company and summarized on investor pages, quarterly earnings dates and investor events are listed on the Labcorp Investor Relations calendar (verify dates on the IR site).

Peers and competitive landscape

Principal peers include other clinical diagnostics and contract research/testing companies. Common comparables include:

• Quest Diagnostics (ticker: DGX) — large diagnostics provider focused on patient testing and lab services.
• ICON plc (ticker: ICLR) — contract research organization supporting clinical development.
• Charles River Laboratories (ticker: CRL) — preclinical and clinical laboratory services for biopharma.
• Bio‑Rad Laboratories (ticker: BIO) — life science research instruments and diagnostics.

When comparing labcorp stock to peers, look at revenue scale, margins (gross and operating), growth rates in diagnostics vs. biopharma services, and valuation multiples. Business mix differences (patient-facing diagnostics vs. CRO revenues) explain much of the variation in multiples across peers.

Risk factors

Investing in labcorp stock involves a range of sector- and company-specific risks. Commonly disclosed risk factors include:

• Regulatory and compliance risk: Clinical laboratories are subject to complex regulation and certification; compliance failures or sanctions can materially affect operations.
• Reimbursement and payer pressure: Changes to public or private payer reimbursement rates can reduce revenues or margins.
• Operational risk: Laboratory capacity constraints, supply chain disruptions, or service continuity issues can affect ability to serve patients and trial customers.
• Biopharma spending cyclicality: Contract research revenues may be sensitive to pharmaceutical R&D cycles and budgets.
• Competition: Pricing and service competition from peers can affect market share and margins.
• Macroeconomic and market risk: Broader economic slowdowns can affect elective testing volumes and capital spending by biopharma clients.

These risks are summarized in detail in Labcorp's SEC filings (Form 10-K and 10-Q) and public disclosures; investors should consult those filings for an exhaustive list and management’s discussion of risk mitigation.

Corporate governance and shareholder actions

Key governance topics for labcorp stock investors include board composition, executive leadership, insider transactions, and capital allocation policies such as share repurchase programs and dividends. The company files proxy statements and Form 4 insider transaction reports that disclose board nominees, executive compensation, and insider trading activity.

Share repurchase authorizations and execution status are reported in quarterly filings; any active buyback program or changes in capital return policy are typically highlighted in earnings releases and investor presentations.

Investing considerations and valuation drivers

Drivers that tend to affect labcorp stock valuation include:

• Organic growth in testing volumes (patient volume recovery, testing mix upgrades).
• Growth in biopharma laboratory services driven by clinical trial activity and pharmaceutical outsourcing trends.
• Margin expansion through productivity, scale advantages, and cost-savings initiatives.
• M&A activity that strategically expands capabilities or geographic reach.
• Regulatory approvals and reimbursement clarity for specialty tests that can expand addressable markets.

Balanced considerations: bullish scenarios emphasize durable demand for diagnostics, continued CRO growth, and operational efficiencies; bearish scenarios highlight reimbursement pressure, slower biopharma spending, or regulatory setbacks. Market commentary and analyst research detail these themes; always corroborate with company filings and independent research.

Historical filings and financial reports

Labcorp's SEC filings (Form 10‑Q, 10‑K, and 8‑K) and investor presentations are the primary authoritative sources for financial results, risk disclosures, and corporate actions. Historical price data and charts are available on the Labcorp IR site and third-party aggregators (Yahoo Finance, MarketWatch, Macrotrends) for backtesting and historical comparisons.

See also

• Quest Diagnostics (DGX)
• ICON plc (ICLR)
• Charles River Laboratories (CRL)
• Bio‑Rad Laboratories (BIO)
• Healthcare sector ETFs and indices

References

The factual and financial details in this guide are compiled from the following primary sources — readers should consult these directly for current numbers and filings:

• Labcorp Investor Relations — corporate profile, press releases, earnings releases, investor presentations (check the IR calendar for latest events). As of 2026-01-26, please confirm dates and figures on the IR site.
• Yahoo Finance — LH quote page for real-time and historical prices and key statistics (check for latest price, market cap, P/E, dividend data).
• MarketWatch — LH quotes and news summaries (verify current metrics and coverage).
• CNBC — company profile and analyst commentary (refer to date-stamped articles for context).
• Finviz — snapshot of summary metrics, institutional holders, and float estimates.
• Macrotrends — historical price series and long-term charts.
• SEC EDGAR — 10-K, 10-Q, 8-K filings for authoritative financial statements and disclosures.

Note: Numerical values such as share price, market capitalization, average volume, and valuation multiples are time-sensitive and must be updated from the live market and the company’s most recent filings.

External links

For real-time quotes and filings, use the Labcorp Investor Relations homepage and the SEC filings database. For market data and analyst summaries, consult major financial data providers and news outlets. When trading or monitoring labcorp stock, consider using a regulated platform such as Bitget for market access and real-time monitoring tools.

Notes on sourcing and currency of data

All quantitative data referenced in this guide are time-sensitive. The preferred primary source for corporate disclosures is Labcorp Investor Relations and SEC filings. For market prices and consensus estimates, use reputable market data providers (Yahoo Finance, MarketWatch, Finviz, Macrotrends, CNBC). When citing a figure in research or making time-sensitive decisions, always include the date of the quote or filing.

Further exploration

If you want to track labcorp stock closely, start with Labcorp’s most recent earnings release and the latest 10-K/10-Q to understand fundamentals. For market monitoring and execution, explore Bitget’s market tools to follow real-time quotes, set alerts, and review analyst coverage summaries. Keep checking the authoritative sources listed above to ensure numerical accuracy.

As of 2026-01-26, readers are advised to verify all numerical figures and event dates on the cited sources (Labcorp IR, Yahoo Finance, MarketWatch, CNBC, Finviz, Macrotrends, and SEC EDGAR) before making any trade or investment-related decision. This article is informational only and not investment advice.